The Norwegian Radium Hospital Research Foundation:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:The Norwegian Radium Hospital Research Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9311
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
The Norwegian Radium Hospital Research Foundation (Radium Hospital) is a research center that conducts research programs and clinical studies. The center invests in oncology, novel therapeutics and diagnostics. It operates as a hub for cancer and oncology treatment research. Radium Hospital serves early-stage biotech companies for the development and commercialization of their products and technologies. The center identifies and promotes research projects and innovations with commercial potential. It serves a network of biotech industry partners, pharmaceutical companies, investors, academic research institutions, universities, university hospitals and unions. Radium Hospital is headquartered in Oslo, Norway.

The Norwegian Radium Hospital Research Foundation – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
The Norwegian Radium Hospital Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
The Norwegian Radium Hospital Research Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
The Norwegian Radium Hospital Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
The Norwegian Radium Hospital Research Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
The Norwegian Radium Hospital Research Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
The Norwegian Radium Hospital Research Foundation, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Zelluna Immunotherapy Receives Financing 10
Targovax Raises US$1.3 Million In Venture Financing 11
Nextera Raises Funds Through Venture Financing 12
Vaccibody Raises US$1 Million In Venture Financing 13
Targovax Raises US$2.2 Million In Series A Financing 14
Equity Offering 15
Targovax Raises USD23.6 Million in Private Placement of Shares 15
Targovax Raises USD26 Million in Private Placement of Shares 17
The Norwegian Radium Hospital Research Foundation – Key Competitors 19
The Norwegian Radium Hospital Research Foundation – Key Employees 20
The Norwegian Radium Hospital Research Foundation – Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
The Norwegian Radium Hospital Research Foundation, Pharmaceuticals & Healthcare, Key Facts 2
The Norwegian Radium Hospital Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
The Norwegian Radium Hospital Research Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
The Norwegian Radium Hospital Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
The Norwegian Radium Hospital Research Foundation, Deals By Therapy Area, 2012 to YTD 2018 8
The Norwegian Radium Hospital Research Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Zelluna Immunotherapy Receives Financing 10
Targovax Raises US$1.3 Million In Venture Financing 11
Nextera Raises Funds Through Venture Financing 12
Vaccibody Raises US$1 Million In Venture Financing 13
Targovax Raises US$2.2 Million In Series A Financing 14
Targovax Raises USD23.6 Million in Private Placement of Shares 15
Targovax Raises USD26 Million in Private Placement of Shares 17
The Norwegian Radium Hospital Research Foundation, Key Competitors 19
The Norwegian Radium Hospital Research Foundation, Key Employees 20

List of Figures
The Norwegian Radium Hospital Research Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
The Norwegian Radium Hospital Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
The Norwegian Radium Hospital Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
The Norwegian Radium Hospital Research Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
The Norwegian Radium Hospital Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
The Norwegian Radium Hospital Research Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
The Norwegian Radium Hospital Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
The Norwegian Radium Hospital Research Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[The Norwegian Radium Hospital Research Foundation:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hokkaido Gas Co Ltd (9534):企業の財務・戦略的SWOT分析
    Summary Hokkaido Gas Co Ltd (Hokkaido Gas), a subsidiary of Kita Gas Group is an oil and gas company that distributes petroleum products. The company’s business activities include gas business, heat supply, power supply, purification and sale of gas by-products, and production and sale of gas applia …
  • LIXIL Group Corporation:企業の戦略・SWOT・財務分析
    LIXIL Group Corporation - Strategy, SWOT and Corporate Finance Report Summary LIXIL Group Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • China Pharma Holdings Inc (CPHI):企業の財務・戦略的SWOT分析
    China Pharma Holdings Inc (CPHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • ConceptoMed AS:医療機器:M&Aディール及び事業提携情報
    Summary ConceptoMed AS (ConceptoMed) is a medical device company that offers medtech systems. The company offers Luer-Jack, a medical syringe facilitating safer conditions for performing medical procedures. Its Luer-Jack provides superior usability advantages, preventing dislodging of the sharp need …
  • Gulf Investment Corporation:企業の戦略的SWOT分析
    Gulf Investment Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Ergon Inc:企業の戦略的SWOT分析
    Ergon Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Thai Beverage Public Company Limited:戦略・SWOT・企業財務分析
    Thai Beverage Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thai Beverage Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Husky Energy Inc (HSE)-石油・ガス分野:企業M&A・提携分析
    Summary Husky Energy Inc. (Husky) is an integrated oil and gas company. The company has operations in upstream and downstream sectors of oil and gas value chain. Its upstream operations include the exploration, development and production of crude oil, bitumen and natural gas. Husky also carried out …
  • Grupo Biotoscana SL (GBIO33):製薬・医療:M&Aディール及び事業提携情報
    Summary Grupo Biotoscana SL (Biotoscana) is a biopharmaceutical company that develops, manufactures and markets advanced medicines for unmet medical needs. The company offers products such as vidaza, ladevina, zyvalix, mielozitidina, votrynib, bozob, timab, enzastar, capebina, leprid, olvestran, toc …
  • PTC Therapeutics Inc (PTCT):製薬・医療:M&Aディール及び事業提携情報
    Summary PTC Therapeutics Inc (PTC Therapeutics) discovers, develops, and commercializes orally active small molecule therapeutics that target post transcriptional control. The company's pipeline products include an orally administered small-molecule targeted at genetic disorders due to a nonsense mu …
  • Mitteldeutsche Braunkohlengesellschaft mbH:企業の戦略的SWOT分析
    Mitteldeutsche Braunkohlengesellschaft mbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Kathmandu Holdings Limited:企業の戦略・SWOT・財務分析
    Kathmandu Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Kathmandu Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • VSTECS Holdings Ltd:企業の戦略・SWOT・財務情報
    VSTECS Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary VSTECS Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Thermax Ltd (THERMAX):企業の財務・戦略的SWOT分析
    Thermax Ltd (THERMAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Antares Pharma Inc (ATRS):企業の財務・戦略的SWOT分析
    Antares Pharma Inc (ATRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Oman Cables Industry SAOG (OCAI):企業の財務・戦略的SWOT分析
    Oman Cables Industry SAOG (OCAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Classic Cosmetics, Inc:企業の戦略・SWOT・財務情報
    Classic Cosmetics, Inc - Strategy, SWOT and Corporate Finance Report Summary Classic Cosmetics, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • L-3 Unmanned Systems, Inc.:企業の戦略・SWOT・財務情報
    L-3 Unmanned Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary L-3 Unmanned Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • John Wiley & Sons, Inc.:企業のM&A・事業提携・投資動向
    John Wiley & Sons, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's John Wiley & Sons, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • ET Solar Group Corporation:電力:M&Aディール及び事業提携情報
    Summary ET Solar Group Corporation (ET Solar) is a provider of renewable energy equipment and services. The company produces a variety of photovoltaic (PV) modules based on global standards such as IEC, TUV, VDE, and UL. It also provides horizontally integrated project development; finance and inves …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆